Tinashe Nyanhete

Tinashe Nyanhete, Ph.D., currently serves as the Associate Director in the Office of the CEO/Portfolio Strategy at Crinetics Pharmaceuticals, a position held since February 2025. Prior experience includes roles as an Associate at Northpond Ventures (2023-2024) and a Consultant at Boston Consulting Group (2020-2023), focusing on high-impact results in the biopharma sector. Tinashe also worked as a Technology Transfer Fellow at Duke's Office for Translation & Commercialization (2018-2019), contributing to scientific and commercial due diligence. Earlier roles include research positions at The National Institutes of Health, Stanford University, and a policy research role at the University of Copenhagen. Tinashe holds a Ph.D. in Immunology from Duke University and a BA in Molecular Biology and Geography from Colgate University.